Skip to content
← Companies
Zoetis

Zoetis

pharma
Parsippany, NJ · ZTS · Public
Zoetis is facing significant legal challenges with multiple securities fraud class action lawsuits filed for alleged material misstatements regarding product adoption between January 2025 and May 2026. The company remains operationally focused on its core animal health business across four manufacturing facilities, but investor confidence appears shaken by litigation.

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.

Employees
13,800
Mfg Plants
3
All Facilities
4
Activity
2/10
Type
Public

ZTS Stock Price

Recent News

Zoetis Deadline: ZTS Investors with Losses in Excess of $100K Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit
GuruFocus · 6/20/2026
Zoetis Deadline: ZTS Investors with Losses in Excess of $100K Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit
PRNewsWire · 6/20/2026
Zoetis Inc. (ZTS) Class Action Lawsuit: Investors July 27 2026, Deadline - Contact KTMC
GuruFocus · 6/19/2026
Zoetis Inc. (ZTS) Class Action Lawsuit: Investors July 27 2026, Deadline - Contact KTMC
PRNewsWire · 6/19/2026
ZOETIS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ZTS
Globe News Wire · 6/19/2026
The Gross Law Firm Reminds Zoetis Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 27, 2026 - ZTS
GlobeNewsWire · 6/19/2026
Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing
Zacks Investment Research · 6/18/2026
ZTS INVESTOR NOTICE: Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
PRNewsWire · 6/18/2026
ZOETIS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ZTS
Newsfile Corp · 6/18/2026
Bragar Eagel & Squire, P.C. Reminds Zoetis, Inc. Investors that a Class Action Lawsuit Has Been Filed Against Zoetis and Encourages Investors to Contact the Firm Before the July 27th Deadline
GlobeNewsWire · 6/18/2026

Manufacturing Plants (3)

Eaton, IN
Eaton, IN
Manufacturing facility for animal health products
Kalamazoo, MI
Kalamazoo, MI
Pharmaceutical manufacturing facility
Lee's Summit, MO
Lee's Summit, MO
Vaccine and pharmaceutical manufacturing

Other Facilities (1)

Parsippany, NJ
Parsippany, NJ · hq
Corporate headquarters